T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 7,193 | 22,305 | 28,058 | 18,130 | 8,335 |
| Cost of Goods | 15,363 | 21,010 | 20,703 | 21,280 | 16,763 |
| Gross Profit | -8,170 | 1,295 | 7,355 | -3,150 | -8,428 |
| Operating Expenses | 41,857 | 56,501 | 51,031 | 38,486 | 44,393 |
| Operating Income | -49,664 | -55,196 | -42,973 | -41,356 | -52,058 |
| Interest Expense | 5,343 | 6,084 | 7,596 | 5,518 | 7,349 |
| Other Income | 4,930 | -723 | 1,328 | 76 | 401 |
| Pre-tax Income | -50,077 | -62,003 | -49,241 | -46,798 | -59,006 |
| Net Income Continuous | -50,077 | -62,003 | -49,241 | -46,798 | -59,006 |
| Net Income | $-50,077 | $-62,003 | $-49,241 | $-46,798 | $-59,006 |
| EPS Basic Total Ops | -19.19 | -1,222.14 | -1,550.00 | -1,950.00 | -6,500.00 |
| EPS Basic Continuous Ops | -19.19 | -1,215.67 | -1,549.81 | -1,928.53 | -6,483.04 |
| EPS Diluted Total Ops | -19.19 | -1,222.14 | -1,550.00 | -1,950.00 | -6,500.00 |
| EPS Diluted Continuous Ops | -19.19 | -1,215.67 | -1,549.81 | -1,928.53 | -6,483.04 |
| EPS Diluted Before Non-Recurring Items | -19.19 | -1,228.00 | -1,550.00 | -1,950.00 | -6,500.00 |
| EBITDA(a) | $-48,805 | $-54,149 | $-40,283 | $-38,128 | $-48,416 |